ImmunoPrecise Antibodies is a biotech and techbio company with roots in British Columbia that supports therapeutic antibody discovery and development. The business combines antibody discovery services with artificial intelligence and multi-omics analysis, and highlights proprietary platforms such as LENSai, HYFT and B Cell Select to support complex biologics programs.